Laumonerie P, Martel M, Tibbo M E, Azoulay V, Mansat P, Bonnevialle N
Department of Orthopedic Surgery, Hôpital Pierre-Paul Riquet, Place du Docteur Baylac, 31059, Toulouse, France.
Laboratoire d'Anthropobiologie AMIS, UMR 5288 CNRS, Université Paul Sabatier, Toulouse, France.
Eur J Orthop Surg Traumatol. 2020 Feb;30(2):221-226. doi: 10.1007/s00590-019-02542-z. Epub 2019 Sep 20.
The primary aim of this study was to determine whether postoperative administration of vitamin C (VC) is associated with reduced risk of complex regional pain syndrome type I (CRPS-I) after subacromial shoulder surgery (SaSS). The secondary objective of the study was to identify risk factor for the development of CRPS-I after SaSS.
A retrospective cohort study was performed to evaluate 542 patients undergoing SaSS from January 2015 to December 2016. The cohort was divided into two groups based on VC administration [Group I (no VC) and Group II (500 mg/day oral VC for 50 days postoperatively)]. The relationship between VC administration and development of CRPS-I was assessed. Demographics, preoperative clinical parameters, and operative variables were evaluated to determine their effect on the incidence of CRPS-I.
A total of 267 patients (Group II) undergoing SaSS received VC, and 266 patients (Group I) did not. The incidence of CRPS-I was significantly different between two groups (36(13%) vs 18(7%), p = 0.009). Multivariable regression, however, demonstrated that VC reduced the risk of CRPS-I after SaSS by > 50% (aOR = 0.49; 95% CI 0.27-0.91). Patients undergoing open surgery (aOR = 2.19; 95% CI 1.2-4.0) were more likely to develop CRPS-I postoperatively. Higher preoperative Constant score (aOR = 0.94; 95% CI 0.91-0.98) was associated with lower risk for CRPS-I development.
The present study found that VC administered prophylactically for 50 days postoperatively is effective in preventing CRPS-I development after SaSS. CRPS-I is a common complication following SaSS, especially in the setting of an open approach. The authors recommend preventive management with VC and arthroscopic approaches when possible for SaSS.
Retrospective comparative study.
本研究的主要目的是确定肩峰下肩部手术(SaSS)后给予维生素C(VC)是否与降低I型复杂性区域疼痛综合征(CRPS-I)的风险相关。本研究的次要目的是确定SaSS后发生CRPS-I的危险因素。
进行一项回顾性队列研究,以评估2015年1月至2016年12月期间接受SaSS的542例患者。根据VC给药情况将队列分为两组[I组(未用VC)和II组(术后50天每天口服500mg VC)]。评估VC给药与CRPS-I发生之间的关系。评估人口统计学、术前临床参数和手术变量,以确定它们对CRPS-I发生率的影响。
共有267例接受SaSS的患者(II组)接受了VC,266例患者(I组)未接受。两组之间CRPS-I的发生率有显著差异(36例[13%]对18例[7%],p = 0.009)。然而,多变量回归表明VC使SaSS后CRPS-I的风险降低>50%(调整后比值比[aOR]=0.49;95%可信区间[CI]0.27-0.91)。接受开放手术的患者(aOR = 2.19;95% CI 1.2-4.0)术后更有可能发生CRPS-I。术前Constant评分较高(aOR = 0.94;95% CI 0.91-0.98)与CRPS-I发生风险较低相关。
本研究发现术后预防性给予VC 50天可有效预防SaSS后CRPS-I的发生。CRPS-I是SaSS后的常见并发症,尤其是在开放手术的情况下。作者建议对SaSS尽可能采用VC预防管理和关节镜手术方法。
证据水平III:回顾性比较研究。